Chronic Hepatitis C

@article{Sharara1997ChronicHC,
  title={Chronic Hepatitis C},
  author={Ala I. Sharara},
  journal={Southern Medical Journal},
  year={1997},
  volume={90},
  pages={872-877}
}
  • A. Sharara
  • Published 1 September 1997
  • Medicine
  • Southern Medical Journal
Background. Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested. The absence of definitive therapy has generated controversy regarding indications and optimal candidacy for currently approved treatment. This paper reviews the… 
Hepatitis B and hepatitis C.
  • S. Geller
  • Medicine
    Clinics in liver disease
  • 2002
Hepatitis B and C are worldwide infectious hepatitides which are distinct in terms of epidemiology and molecular biology, but which may be quite similar in terms of clinical manifestations and
Hyperlipasemia Associated with Hepatitis C Virus
TLDR
In conclusion, hyperlipasemia and/or subclinical pancreatitis may represent extrahepatic manifestations of HCV infection and should not preclude treatment.
Ozone Therapy in Patients with Viral Hepatitis C: Ten Years' Experience
TLDR
It was found that, following 8 weeks of ozone therapy, the viral load decreased in 91.67% of the cases attaining negative PCR in 20%, and there was a statistically significant improvement as regards the parameters of SGOT, SGPT, albumin, bilirubin and prothrombin after 8 weeks from the start of the study.
Molecular mechanisms of poliovirus persistence: key role of capsid determinants during the establishment phase
TLDR
The results permit us to propose several hypotheses concerning PV persistence and the early steps of the PV cycle, and in particular, the conformational modifications of the capsid following virus adsorption onto its receptor.